Increasingly, the care of lung cancer patients has become a multi-doctor, multi-disciplinary job. Gone are the days (thankfully!) when a paternalistic doctor prescribed a treatment plan that was unquestioned by the patient. The internet and ease of travel have allowed unprecedented access to information and to physicians. As more treatment options and strategies become available for lung cancer patients, it is inevitable that they will be faced with differing opinions from their physicians with regard to how to personalize their care. Examples are plentiful, such as decisions between surgery or radiation therapy… Read More
- #LCSM Chat 11/29: What’s a cancer model, and why should I care?
- #LCSM Chat Topic 11/15/2018: #LCAM Open Mic Nite
- #LCSM Chat Topic 11/1: #LCAM and the Evolution of Lung Cancer Advocacy
- #LCSM Chat Topic 10/18/2018: Lung Cancer Screening: Never a Better Time Than Now
- #LCSM Chat Topic 10/04/2018: Highlights from #WCLC2018
#LCAM14 ALK biomarker cancer treatment plans clinical research clinical trials Drugs EGFR epatients FDA immunotherapy LDCT lung cancer lung cancer awareness month lung cancer risk factors lung cancer screening Medicare coverage of LDCT over-treatment patient advocates PCORI Screening self-advocacy shared decision making trials World Cancer Day